Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

University of Toronto

$159,947.00

Development of Machine Learning to Assess Lung Function Using Airway Oscillometry

EF 2019-20

Résumé
Pulmonary function (PF) tests are useful tools to diagnose and monitor lung disease. The gold standard test uses spirometry to measure FEV1 (forced expiratory volume in 1 sec). However, FEV1 only measures the large airways although many lung diseases begin in the small airways (SAw). If we could measure SAw function accurately, we could detect and treatlung diseases earlier. Airway oscillometry (OSc) measures SAw function accurately but OSc outputs are complex and difficult to interpret. For these reasons, OSc is not commonly used. To improve the clinical utility of OSc, we will develop machine learning (ML) to classify OSc outputs as normal or SAw obstruction. ML will learn from spirometry and OSc data of bonemarrow and lung transplant patients who undergo frequent PF testing because SAw obstruction develops often post-transplant. A large dataset with a wide range of normal/abnormal lung function values are important features that will allow ML to develop with high predictive accuracy.We will then validate the ML algorithm in patients with confirmed SAw obstruction. We will also assess the wider applicability of OSc and ML in the general population in 2 community PF laboratories with diverse lung diseases, and a community cohort in Fort McMurray. The project is led by a Lung Specialist (Chow) and Engineer with expertise in ML (Valaee). Our partners are appropriate: University Health Network is a world leading centre in lung diseases. Thorasys, a Canadian company, developed the only Health Canada approved OSc device. Earlier diagnosis of lung disease using ML with OSc will improve the health of Canadians and decrease the overall health burden. The project contributes to human resource development by providing rich learning experiences for graduate students and cardiopulmonary function technologists in Medicine and Engineering. The project adds to the Canadian economy by contributing to the medical device development and manufacturing in Canada.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
538796-2019
Name nom
Chow, ChungWai
Department département
Medicine, Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
159947
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Development of Machine Learning to Assess Lung Function Using Airway Oscillometry
Keyword
NSERC
Application summary
Pulmonary function (PF) tests are useful tools to diagnose and monitor lung disease. The gold standard test uses spirometry to measure FEV1 (forced expiratory volume in 1 sec). However, FEV1 only measures the large airways although many lung diseases begin in the small airways (SAw). If we could measure SAw function accurately, we could detect and treatlung diseases earlier. Airway oscillometry (OSc) measures SAw function accurately but OSc outputs are complex and difficult to interpret. For these reasons, OSc is not commonly used. To improve the clinical utility of OSc, we will develop machine learning (ML) to classify OSc outputs as normal or SAw obstruction. ML will learn from spirometry and OSc data of bonemarrow and lung transplant patients who undergo frequent PF testing because SAw obstruction develops often post-transplant. A large dataset with a wide range of normal/abnormal lung function values are important features that will allow ML to develop with high predictive accuracy.We will then validate the ML algorithm in patients with confirmed SAw obstruction. We will also assess the wider applicability of OSc and ML in the general population in 2 community PF laboratories with diverse lung diseases, and a community cohort in Fort McMurray. The project is led by a Lung Specialist (Chow) and Engineer with expertise in ML (Valaee). Our partners are appropriate: University Health Network is a world leading centre in lung diseases. Thorasys, a Canadian company, developed the only Health Canada approved OSc device. Earlier diagnosis of lung disease using ML with OSc will improve the health of Canadians and decrease the overall health burden. The project contributes to human resource development by providing rich learning experiences for graduate students and cardiopulmonary function technologists in Medicine and Engineering. The project adds to the Canadian economy by contributing to the medical device development and manufacturing in Canada.